SonoSite launches 180 system

Article

Hand-held ultrasound manufacturer SonoSite has begun shipping its SonoSite 180 ultrasound system worldwide. SonoSite received the CE Mark Sept. 15 for the system. The certification gives the Bothell, WA, company rights to distribute the system throughout

Hand-held ultrasound manufacturer SonoSite has begun shipping its SonoSite 180 ultrasound system worldwide. SonoSite received the CE Mark Sept. 15 for the system. The certification gives the Bothell, WA, company rights to distribute the system throughout the European Union.

The 5-lb unit allows for color power Doppler capability and uses digital broadband beam-forming technology. SonoSite received 510(k) clearance from the Food and Drug Administration for SonoSite 180 in April (SCAN 4/28/99) for such indications as gynecology, obstetrics, and abdominal imaging. The system is configured to offer both transabdominal and intravaginal imaging, according to SonoSite.

In other SonoSite news, the company has joined Office of the Future, a research and development consortium that is working to create a clinical office model that integrates technology, information, and design. The group plans to use SonoSite 180 in the exam and procedure rooms it is developing. Office of the Future includes such companies as Midmark, American Express Healthcare Finance, American Medical Development, GE Marquette Medical Systems, Health Care Data Systems, Hewlett-Packard, Lunar, and Sony Electronics Medical Systems.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.